Multimodality imaging in interventional cardiology

Nature Reviews Cardiology

Volumn 9, Issue 6, 2012, Pages 333-346

  Van Der Hoeven, Bas L ^a   Schalij, Martin J ^a   Delgado, Victoria ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BMS 753951; CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; RP 748; UNCLASSIFIED DRUG;

ANGIOCARDIOGRAPHY; ATHEROSCLEROTIC PLAQUE; CARDIAC RESYNCHRONIZATION THERAPY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST ENHANCEMENT; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DOPPLER ECHOCARDIOGRAPHY; EARLY DIAGNOSIS; ELECTRON BEAM TOMOGRAPHY; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART MUSCLE PERFUSION; HUMAN; HYBRID IMAGING; LEFT VENTRICULAR MECHANICAL DYSSYNCHRONY; MITRAL VALVE REGURGITATION; MOLECULAR IMAGING; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIMODALITY IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE;

ANIMALS; CARDIAC RESYNCHRONIZATION THERAPY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; HEART CATHETERIZATION; HEART DISEASES; HEART FAILURE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MOLECULAR IMAGING; POSITRON-EMISSION TOMOGRAPHY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOGRAPHY, INTERVENTIONAL; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84861482857     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2012.14     Document Type: Review

References (105)

1. Roger, V. L. et al. Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation 123, e18-e209 (2011).
2. Heidenreich, P. A. et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 123, 933-944 (2011).
3. Berman, D. S. Fourth annual Mario S. Verani, MD Memorial Lecture: noninvasive imaging in coronary artery disease: changing roles, changing players. J. Nucl. Cardiol. 13, 457-473 (2006).
4. Klocke, F. J. et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC committee to revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging). Circulation 108, 1404-1418 (2003).
5. Virmani, R., Kolodgie, F. D., Burke, A. P., Farb, A. & Schwartz, S. M. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 20, 1262-1275 (2000).
6. Nahrendorf, M. et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 114, 1504-1511 (2006).
7. Rudd, J. H. et al. 18Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J. Am. Coll. Cardiol. 50, 892-896 (2007).
8. Tawakol, A. et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J. Am. Coll. Cardiol. 48, 1818-1824 (2006).
9. Nekolla, S. G., Martinez-Moeller, A. & Saraste, A. PET and MRI in cardiac imaging: from validation studies to integrated applications. Eur. J. Nucl. Med. Mol. Imaging 36 (Suppl. 1), S121-S130 (2009).
10. Underwood, S. R. et al. Myocardial perfusion scintigraphy: the evidence. Eur. J. Nucl. Med. Mol. Imaging 31, 261-291 (2004).
11. Lima, R. S. et al. Incremental value of combined perfusion and function over perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe three-vessel coronary artery disease. J. Am. Coll. Cardiol. 42, 64-70 (2003).
12. Petretta, M., Soricelli, A., Storto, G. & Cuocolo, A. Assessment of coronary flow reserve using single photon emission computed tomography with technetium 99m-labeled tracers. J. Nucl. Cardiol. 15, 456-465 (2008).
13. Go, R. T. et al. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J. Nucl. Med. 31, 1899-1905 (1990).
14. Di Carli, M. F. & Hachamovitch, R. New technology for noninvasive evaluation of coronary artery disease. Circulation 115, 1464-1480 (2007).
15. Bax, J. J. et al. Diagnostic and clinical perspectives of fusion imaging in cardiology: is the total greater than the sum of its parts? Heart 93, 16-22 (2007).
16. Budoff, M. J. et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J. Am. Coll. Cardiol. 49, 1860-1870 (2007).
17. Greenland, P. et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA writing committee to update the 2000 expert consensus document on electron beam computed tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J. Am. Coll. Cardiol. 49, 378-402 (2007).
18. Kitagawa, T. et al. Characterization of noncalcified coronary plaques and identification of culprit lesions in patients with acute coronary syndrome by 64-slice computed tomography. JACC Cardiovasc. Imaging 2, 153-160 (2009).
19. van Werkhoven, J. M. et al. Prognostic value of multislice computed tomography and gated single-photon emission computed tomography in patients with suspected coronary artery disease. J. Am. Coll. Cardiol. 53, 623-632 (2009).
20. Groves, A. M. et al. First experience of combined cardiac PET/64-detector CT angiography with invasive angiographic validation. Eur. J. Nucl. Med. Mol. Imaging 36, 2027-2033 (2009).
21. Kajander, S. et al. Cardiac positron emission tomography/computed tomography imaging accurately detects anatomically and functionally significant coronary artery disease. Circulation 122, 603-613 (2010).
22. Namdar, M. et al. Integrated PET/CT for the assessment of coronary artery disease: a feasibility study. J. Nucl. Med. 46, 930-935 (2005).
23. Rispler, S. et al. Integrated single-photon emission computed tomography and computed tomography coronary angiography for the assessment of hemodynamically significant coronary artery lesions. J. Am. Coll. Cardiol. 49, 1059-1067 (2007).
24. Sato, A. et al. Incremental value of combining 64-slice computed tomography angiography with stress nuclear myocardial perfusion imaging to improve noninvasive detection of coronary artery disease. J. Nucl. Cardiol. 17, 19-26 (2010).
25. Schepis, T. et al. Added value of coronary artery calcium score as an adjunct to gated SPECT for the evaluation of coronary artery disease in an intermediate-risk population. J. Nucl. Med. 48, 1424-1430 (2007).
26. Shaw, L. J., Raggi, P., Schisterman, E., Berman, D. S. & Callister, T. Q. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology 228, 826-833 (2003).
27. Schenker, M. P. et al. Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography/computed tomography study. Circulation 117, 1693-1700 (2008).
28. Gaemperli, O. et al. Coronary CT angiography and myocardial perfusion imaging to detect flow-limiting stenoses: a potential gatekeeper for coronary revascularization? Eur. Heart J. 30, 2921-2929 (2009).
29. Pazhenkottil, A. P. et al. Prognostic value of cardiac hybrid imaging integrating single-photon emission computed tomography with coronary computed tomography angiography. Eur. Heart J. 32, 1465-1471 (2011).
30. Stehning, C., Boernert, P. & Nehrke, K. Advances in coronary MRA from vessel wall to whole heart imaging. Magn. Reson. Med. Sci. 6, 157-170 (2007).
31. Raggi, P. et al. Atherosclerotic plaque imaging: contemporary role in preventive cardiology. Arch. Intern. Med. 165, 2345-2353 (2005).
32. Kim, W. Y. et al. Three-dimensional black-blood cardiac magnetic resonance coronary vessel wall imaging detects positive arterial remodeling in patients with nonsignificant coronary artery disease. Circulation 106, 296-299 (2002).
33. Macedo, R. et al. MRI detects increased coronary wall thickness in asymptomatic individuals: the multi-ethnic study of atherosclerosis (MESA). J. Magn. Reson. Imaging 28, 1108-1115 (2008).
34. Johnstone, M. T. et al. In vivo magnetic resonance imaging of experimental thrombosis in a rabbit model. Arterioscler. Thromb. Vasc. Biol. 21, 1556-1560 (2001).
35. Moreno, P. R. et al. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 90, 775-778 (1994).
36. von Bary, C. et al. MRI of coronary wall remodeling in a swine model of coronary injury using an elastin-binding contrast agent. Circ. Cardiovasc. Imaging 4, 147-155 (2011).
37. Corti, R. & Fuster, V. Imaging of atherosclerosis: magnetic resonance imaging. Eur. Heart J. 32, 1709-1719 (2011).
38. Rudd, J. H. et al. Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? J. Am. Coll. Cardiol. 55, 2527-2535 (2010).
39. Rogers, I. S. et al. Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina. JACC Cardiovasc. Imaging 3, 388-397 (2010).
40. Leuschner, F. & Nahrendorf, M. Molecular imaging of coronary atherosclerosis and myocardial infarction: considerations for the bench and perspectives for the clinic. Circ. Res. 108, 593-606 (2011).
41. Laitinen, I. et al. Evaluation of ávâ3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice. Circ. Cardiovasc. Imaging 2, 331-338 (2009).
42. Flotats, A. et al. Hybrid cardiac imaging: SPECT/CT and PET/CT. A joint position statement by the European Association of Nuclear Medicine (EANM), the European Society of Cardiac Radiology (ESCR) and the European Council of Nuclear Cardiology (ECNC). Eur. J. Nucl. Med. Mol. Imaging 38, 201-212 (2011).
43. Sinusas, A. J. et al. Multimodality cardiovascular molecular imaging, part I. Circ. Cardiovasc. Imaging 1, 244-256 (2008).
44. Rudd, J. H. et al. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J. Nucl. Med. 49, 871-878 (2008).
45. Sadeghi, M. M. et al. Detection of injury-induced vascular remodeling by targeting activated ávâ3 integrin in vivo. Circulation 110, 84-90 (2004).
46. Schafers, M. et al. Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo. Circulation 109, 2554-2559 (2004).
47. Terrovitis, J. et al. Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. J. Am. Coll. Cardiol. 54, 1619-1626 (2009).
48. Knuuti, J. & Bengel, F. M. Positron emission tomography and molecular imaging. Heart 94, 360-367 (2008).
49. Rudd, J. H. et al. Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? J. Am. Coll. Cardiol. 55, 2527-2535 (2010).
50. Wu, J. C., Bengel, F. M. & Gambhir, S. S. Cardiovascular molecular imaging. Radiology 244, 337-355 (2007).
51. McAlister, F. A. et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA 297, 2502-2514 (2007).
52. Epstein, A. E. et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 51, 2085-2105 (2008).
53. Linde, C. et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J. Am. Coll. Cardiol. 52, 1834-1843 (2008).
54. Moss, A. J. et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N. Engl. J. Med. 361, 1329-1338 (2009).
55. Tang, A. S. et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N. Engl. J. Med. 363, 2385-2395 (2010).
56. Dickstein, K. et al. 2010 focused update of ESC guidelines on device therapy in heart failure: an update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur. J. Heart Fail. 12, 1143-1153 (2010).
57. Delgado, V. & Bax, J. J. Assessment of systolic dyssynchrony for cardiac resynchronization therapy is clinically useful. Circulation 123, 640-655 (2011).
58. Delgado, V. et al. Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapy. Circulation 123, 70-78 (2011).
59. Chung, E. S. et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 117, 2608-2616 (2008).
60. Bilchick, K. C. et al. Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapy. JACC Cardiovasc. Imaging 1, 561-568 (2008).
61. Khan, F. Z. et al. Targeted left ventricular lead placement using speckle tracking echocardiography improves the acute hemodynamic response to cardiac resynchronization therapy: a randomized controlled trial [abstract]. J. Am. Coll. Cardiol. 57, aE2033 (2011).
62. Gorcsan III, J. et al. Relationship of echocardiographic dyssynchrony to long-term survival after cardiac resynchronization therapy. Circulation 122, 1910-1918 (2010).
63. Amundsen, B. H. et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J. Am. Coll. Cardiol. 47, 789-793 (2006).
64. Leyva, F. et al. Development and validation of a clinical index to predict survival after cardiac resynchronisation therapy. Heart 95, 1619-1625 (2009).
65. Auger, D., Schalij, M. J., Bax, J. J. & Delgado, V. Three-dimensional imaging in cardiac resynchronization therapy. Rev. Esp. Cardiol. 64, 1035-1044 (2011).
66. Sutton, M. G. et al. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Circulation 113, 266-272 (2006).
67. Wikstrom, G. et al. The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial. Eur. Heart J. 30, 782-788 (2009).
68. Bleeker, G. B. et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 113, 969-976 (2006).
69. Ypenburg, C. et al. Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy. Am. J. Cardiol. 99, 657-660 (2007).
70. Kim, R. J. et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N. Engl. J. Med. 343, 1445-1453 (2000).
71. Singh, J. P. et al. Left ventricular lead position and clinical outcome in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT) Trial. Circulation 123, 1159-1166 (2011).
72. Auricchio, A. et al. Characterization of left ventricular activation in patients with heart failure and left bundle-branch block. Circulation 109, 1133-1139 (2004).
73. Butter, C. et al. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation 104, 3026-3029 (2001).
74. Helm, R. H. et al. Three-dimensional mapping of optimal left ventricular pacing site for cardiac resynchronization. Circulation 115, 953-961 (2007).
75. Ypenburg, C. et al. Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J. Am. Coll. Cardiol. 52, 1402-1409 (2008).
76. Giraldi, F. et al. Long-term effectiveness of cardiac resynchronization therapy in heart failure patients with unfavorable cardiac veins anatomy comparison of surgical versus hemodynamic procedure. J. Am. Coll. Cardiol. 58, 483-490 (2011).
77. Uebleis, C. et al. Electrocardiogram-gated 18F-FDG PET/CT hybrid imaging in patients with unsatisfactory response to cardiac resynchronization therapy: initial clinical results. J. Nucl. Med. 52, 67-71 (2011).
78. Duckett, S. G. et al. Advanced image fusion to overlay coronary sinus anatomy with real-time fluoroscopy to facilitate left ventricular lead implantation in CRT. Pacing Clin. Electrophysiol. 34, 226-234 (2011).
79. Abraham, W. T. & Hayes, D. L. Cardiac resynchronization therapy for heart failure. Circulation 108, 2596-2603 (2003).
80. Duckett, S. G. et al. A novel cardiac MRI protocol to guide successful cardiac resynchronization therapy implantation. Circ. Heart Fail. 3, e18-e21 (2010).
81. Nkomo, V. T. et al. Burden of valvular heart diseases: a population-based study. Lancet 368, 1005-1011 (2006).
82. Carabello, B. A. & Paulus, W. J. Aortic stenosis. Lancet 373, 956-966 (2009).
83. Iung, B. et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur. Heart J. 26, 2714-2720 (2005).
84. Mirabel, M. et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur. Heart J. 28, 1358-1365 (2007).
85. Zajarias, A. & Cribier, A. G. Outcomes and safety of percutaneous aortic valve replacement. J. Am. Coll. Cardiol. 53, 1829-1836 (2009).
86. Delgado, V. et al. Multimodality imaging before, during, and after percutaneous mitral valve repair. Heart 97, 1704-1714 (2011).
87. Vahanian, A. Transcatheter aortic valve implantation: a snapshot from the United Kingdom. J. Am. Coll. Cardiol. 58, 2139-2140 (2011).
88. Kempfert, J. et al. Automatically segmented DynaCT: enhanced imaging during transcatheter aortic valve implantation. J. Am. Coll. Cardiol. 58, e211 (2011).
89. Alfieri, O. et al. Novel suture device for beating-heart mitral leaflet approximation. Ann. Thorac. Surg. 74, 1488-1493 (2002).
90. Feldman, T. et al. Percutaneous repair or surgery for mitral regurgitation. N. Engl. J. Med. 364, 1395-1406 (2011).
91. Franzen, O. et al. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur. Heart J. 31, 1373-1381 (2010).
92. Tamburino, C. et al. Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting. Eur. Heart J. 31, 1382-1389 (2010).
93. Mauri, L. et al. The EVEREST II trial: design and rationale for a randomized study of the evalve mitraclip system compared with mitral valve surgery for mitral regurgitation. Am. Heart J. 160, 23-29 (2010).
94. Shanks, M. et al. Quantitative assessment of mitral regurgitation: comparison between three-dimensional transesophageal echocardiography and magnetic resonance imaging. Circ. Cardiovasc. Imaging 3, 694-700 (2010).
95. Zamorano, J. L. et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur. J. Echocardiogr. 12, 557-584 (2011).
96. Cribier, A. et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106, 3006-3008 (2002).
97. Leon, M. B. et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med. 363, 1597-1607 (2010).
98. Smith, C. R. et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N. Engl. J. Med. 364, 2187-2198 (2011).
99. Schultz, C. J. et al. Three dimensional evaluation of the aortic annulus using multislice computer tomography: are manufacturer's guidelines for sizing for percutaneous aortic valve replacement helpful? Eur. Heart J. 31, 849-856 (2010).
100. Messika-Zeitoun, D. et al. Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation. J. Am. Coll. Cardiol. 55, 186-194 (2010).
101. Ng, A. C. et al. Comparison of aortic root dimensions and geometries before and after transcatheter aortic valve implantation by 2-and 3-dimensional transesophageal echocardiography and multislice computed tomography. Circ. Cardiovasc. Imaging 3, 94-102 (2010).
102. Koos, R. et al. Evaluation of aortic root for definition of prosthesis size by magnetic resonance imaging and cardiac computed tomography: Implications for transcatheter aortic valve implantation. Int. J. Cardiol. http://dx.doi.org/10.1016/j.ijcard.2011.01.044.
103. Vahanian, A. et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 29, 1463-1470 (2008).
104. Delgado, V. et al. Multimodality imaging in transcatheter aortic valve implantation: key steps to assess procedural feasibility. EuroIntervention 6, 643-652 (2010).
105. Horvath, K. A. et al. Midterm results of transapical aortic valve replacement via real-time magnetic resonance imaging guidance. J. Thorac. Cardiovasc. Surg. 139, 424-430 (2010).